Trials / Unknown
UnknownNCT05882084
Oral Supplementation of Astaxanthin on Skin Photoaging, Hydration and Elasticity
Double Blind Placebo Controlled Oral Supplementation of Astaxanthin on Skin Photoaging, Hydration and Elasticity
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- Integrative Skin Science and Research · Industry
- Sex
- Female
- Age
- 30 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This study is a double-blind placebo controlled study to assess whether oral astaxanthin can improve skin hydration, skin elasticity, improve skin pigmentation, and reduce facial redness.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Astaxanthin 6 mg daily | Astaxanthin at 6 mg is given for daily ingestion and compared against placebo. |
| DIETARY_SUPPLEMENT | Placebo | Placebo |
Timeline
- Start date
- 2023-07-24
- Primary completion
- 2023-09-30
- Completion
- 2023-12-31
- First posted
- 2023-05-31
- Last updated
- 2023-07-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05882084. Inclusion in this directory is not an endorsement.